UK Quarantine Policy:
India's pressure on Britain regarding the Covishield vaccine is working, although the issue is still the same. The UK has approved the Serum Institute's 'Coveshield' in its new travel rules, but Indians going to the UK will still have to stay in Quarantine. The UK government on Wednesday included India-made Oxford/AstraZeneca's anti-Covid-19 vaccine Covishield in its updated international travel advisory, but the change in travel rules will not benefit Indians much.
Earlier, the UK's new travel rule did not recognize Covid-19 vaccination for people taking both doses of the Covishield vaccine, made by the Serum Institute of India. Along with this, on reaching Britain, Indians were directed to stay in Quarantine and this decision of Britain was widely condemned.
Britain has now approved the Covishield by changing its travel policy, but it has not considering India's Covid-19 vaccine certificate, due to which there will be no significant change for Indian travelers to the country.
According to the new rule, people coming from Australia, Antigua and Barbuda, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea, Taiwan, and UAE will be considered completely vaccinated.
While there are three different lists of red, amber, and green made in relation to the trip to Britain and considering the danger factor, different countries have been kept in different lists. From 4th October, all the lists will be merged and only the red list will remain. Travelers from countries included in the Red List will face restrictions on travel to the UK.
India is still on the amber list and in such a situation, eliminating the Amber list means that only a few passengers will be exempted from the PCR test. India is not included in the countries whose Covid-19 vaccines will be approved in the UK. This means that Indians who have got the Covidshield vaccine from the Serum Institute of India will have to compulsorily undergo a PCR test and stay in quarantine at the designated addresses.